SynthesisNeurosurgical review2025
Fully endoscopic microvascular decompression for hemifacial spasm: a systematic review.
Synthesis in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Transcranial fully endoscopic clipping techniques for ruptured aneurysms: an initial experience from a single center.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemifacial spasm (HFS) is a distressing condition caused by facial nerve compression and characterized by involuntary facial muscle twitching, adversely impacting quality of life. Microvascular decompression (MVD) is effective but poses risks. Fully endoscopic MVD (E-MVD) as an emerging technique offers enhanced safety and efficacy. Therefore, this systematic review aimed to evaluate the use of fully E-MVD in treating HFS. In accordance with PRISMA guidelines, the systematic review included a thorough literature search in PubMed/MEDLINE, Embase, and Cochrane Library. Eligible studies were evaluated based on predefined criteria, with duplicates eliminated and conflicts resolved by a senior author. Data extraction was performed independently by two authors, with disagreements resolved by the senior author. Details on study characteristics, demographics, intraoperative observations, postoperative complications, and efficacy of fully E-MVD for HFS were gathered. Quality assessment was conducted using the NIH tool. A total of 408 patients were included in the study, with females comprising 68% and males 32% of the cohort. The mean age of patients was 52.4 years, with an average symptom duration of 4.5 years. Right-sided and left-sided symptoms were reported in 54.4% and 46.6% of patients, respectively. Intraoperatively, the most common offending blood vessel was a single AICA (48.1%). Early postoperative complications were reported in 13.6% of patients, which primarily consisted of transient facial palsy (6.8%) and hearing impairment (4%). All cases of facial palsy resolved during the follow-up period, yet 1.3% of hearing impairments persisted. The efficacy of Fully E-MVD for HFS was promising, with 93.3% of patients experiencing effective resolution at follow-up. With advancements in surgical techniques and technology, fully E-MVD continues to show promising results in improving the quality of life for patients suffering from HFS. Favorable outcomes and symptom resolution support fully E-MVD's advantages. Surgeons must consider limitations and proper techniques for optimal patient outcomes.
Indexed as
Identifiers
40050528What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.